Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
xhvGxfzn769Dd4zY